{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:45Z","timestamp":1788416025367,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Ovarian cancer (OC) remains a leading cause of gynecologic cancer mortality worldwide because early symptoms are often vague, effective population-level screening strategies are lacking, and outcomes are shaped by biological heterogeneity and unequal access to diagnostic and molecular testing resources. This Mini Review summarizes advances from 2021 to 2026 in artificial intelligence (AI) applications across the OC care continuum, focusing on early detection, treatment decision-making, prognostic assessment, clinical implementation, and health equity. This review maps AI applications against current clinical limitations, established benchmark tools, translational readiness, and equity-related implementation gaps. In detection, AI models integrate multimarker blood panels, routine laboratory indicators, ultrasound imaging, and cell-free DNA (cfDNA)-derived molecular signals to improve risk stratification beyond traditional biomarkers such as CA125, although prospective validation remains limited. In treatment and prognosis, pathology-based, radiomics-based, omics-based, and multimodal AI models show potential for predicting homologous recombination deficiency (HRD), platinum response, recurrence risk, and survival outcomes, but most remain retrospective or externally validated rather than clinically deployed. Blood\/laboratory-based and ultrasound-assisted AI appear closest to workflow-based evaluation, whereas cfDNA-based screening, population-level AI detection, and multimodal prognostic models remain preliminary. Future efforts should prioritize prospective multicenter studies, benchmarked evaluation, transparent reporting, cost-effectiveness analysis, workflow integration, and globally representative datasets. Ultimately, AI should be judged by its ability to improve timely, affordable, and equitable OC care.<\/jats:p>","DOI":"10.3389\/fonc.2026.1915221","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:23:34Z","timestamp":1788413014000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence in ovarian cancer prevention and control: a brief review of detection, treatment, and equity (2021\u20132026)"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhenyu","family":"Huang","sequence":"first","affiliation":[{"name":"School of Humanities and Social Sciences, Harbin Engineering University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Wei","sequence":"additional","affiliation":[{"name":"School of Humanities and Social Sciences, Harbin Engineering University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Heilongjiang University of Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001867","article-title":"Outcomes of women with high-grade and low-grade advanced-stage serous epithelial ovarian cancer","volume":"129","author":"Gockley","year":"2017","journal-title":"Obstet Gynecol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104611","article-title":"Ovarian cancer\u2014epidemiology, classification, pathogenesis, treatment, and estrogen receptors\u2019 molecular backgrounds","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"Platinum resistant ovarian cancer: what is it, who to treat and how to measure benefit","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13048-026-01979-1","article-title":"Artificial intelligence (AI) and machine learning (ML) in ovarian cancer: transforming detection, treatment, and prevention","volume":"19","author":"Singh","year":"2026","journal-title":"J Ovarian Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.21.00192","article-title":"Analytical validation of a deep neural network algorithm for the detection of ovarian cancer","volume":"6","author":"Reilly","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(23)00245-5","article-title":"Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study","volume":"6","author":"Cai","year":"2024","journal-title":"Lancet Digit Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"18625","DOI":"10.1038\/s41598-022-23149-1","article-title":"Precision gynecologic oncology: circulating cell-free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer","volume":"12","author":"Bahado-Singh","year":"2022","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1038\/s41467-024-48667-6","article-title":"Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer","volume":"15","author":"Ahn","year":"2024","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02641","article-title":"Deep learning artificial intelligence predicts homologous recombination deficiency and platinum response from histologic slides","volume":"42","author":"Bergstrom","year":"2024","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41698-025-01263-3","article-title":"Survival prediction and risk stratification in R0-resected ovarian cancer: a multi-modal deep learning approach","volume":"10","author":"Zhou","year":"2026","journal-title":"NPJ Precis Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113532","article-title":"Prediction of prognosis and treatment response in ovarian cancer patients from histopathology images using graph deep learning: a multicenter retrospective study","volume":"199","author":"Yang","year":"2024","journal-title":"Eur J Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2026.105126","article-title":"Artificial intelligence applications in ovarian cancer detection: a systematic literature review of deep learning approaches and clinical translation challenges","volume":"219","author":"G\u00fclmez","year":"2026","journal-title":"Crit Rev Oncol Hematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2025.104452","article-title":"Artificial intelligence for single-omics in ovarian cancer: a methodological review","volume":"36","author":"Ord\u00e1s","year":"2026","journal-title":"Int J Gynecol Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13048-024-01365-9","article-title":"An integrated machine learning-based model for joint diagnosis of ovarian cancer with multiple test indicators","volume":"17","author":"Feng","year":"2024","journal-title":"J Ovarian Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2196\/67922","article-title":"AI-derived blood biomarkers for ovarian cancer diagnosis: systematic review and meta-analysis","volume":"27","author":"Xu","year":"2025","journal-title":"J Med Internet Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102923","article-title":"Development and validation of a deep learning pipeline to diagnose ovarian masses using ultrasound screening: a retrospective multicenter study","volume":"78","author":"Dai","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12880-024-01251-2","article-title":"Ultrasound-based deep learning radiomics model for differentiating benign, borderline, and Malignant ovarian tumours: a multi-class classification exploratory study","volume":"24","author":"Du","year":"2024","journal-title":"BMC Med Imaging"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109403","article-title":"Multi-modality deep learning model reaches high prediction accuracy in the diagnosis of ovarian cancer","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"B22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41698-026-01320-5","article-title":"Development and validation of an artificial intelligence-based model for diagnosing benign, borderline, and Malignant adnexal masses","volume":"10","author":"Wu","year":"2026","journal-title":"NPJ Precis Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13148-022-01285-9","article-title":"Detection of ovarian cancer using plasma cell-free DNA methylomes","volume":"14","author":"Lu","year":"2022","journal-title":"Clin Epigenet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34757","article-title":"Plasma cell-free DNA methylation analysis for ovarian cancer detection: analysis of samples from a case-control study and an ovarian cancer screening trial","volume":"154","author":"Herzog","year":"2024","journal-title":"Int J Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0393","article-title":"Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers","volume":"15","author":"Medina","year":"2025","journal-title":"Cancer Discov"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2196\/48527","article-title":"Predictive value of machine learning for platinum chemotherapy responses in ovarian cancer: systematic review and meta-analysis","volume":"26","author":"Wang","year":"2024","journal-title":"J Med Internet Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19123","DOI":"10.1038\/s41598-025-99930-9","article-title":"Integrating bulk RNA-seq and scRNA-seq analyses with machine learning to predict platinum response and prognosis in ovarian cancer","volume":"15","author":"Gao","year":"2025","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12885-024-11989-1","article-title":"Comprehensive machine learning-based preoperative blood features predict the prognosis for ovarian cancer","volume":"24","author":"Wu","year":"2024","journal-title":"BMC Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1186\/s12885-025-14265-y","article-title":"A CT-based radiomics model for predicting progression-free survival in patients with epithelial ovarian cancer","volume":"25","author":"Leng","year":"2025","journal-title":"BMC Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14020348","article-title":"MMHC-OCPR: prediction of platinum response and recurrence risk in ovarian cancer with multimodal deep learning","volume":"14","author":"Tang","year":"2026","journal-title":"Biomedicines"},{"key":"B31","doi-asserted-by":"publisher","first-page":"14437","DOI":"10.1038\/s41598-025-98434-w","article-title":"A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy","volume":"15","author":"Ma","year":"2025","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK-25-473930","article-title":"Global oncology: tackling disparities and promoting innovations in low- and middle-income countries","volume":"45","author":"Barragan-Carrillo","year":"2025","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.landig.2025.100937","article-title":"Leveraging digital technologies to reduce cancer disparities in low-income and middle-income countries","volume":"7","author":"Gichoya","year":"2025","journal-title":"Lancet Digit Health"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020422","article-title":"Artificial intelligence in ultrasound diagnoses of ovarian cancer: a systematic review and meta-analysis","volume":"16","author":"Mitchell","year":"2024","journal-title":"Cancers"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01772-9","article-title":"Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI","volume":"28","author":"Vasey","year":"2022","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04951-6","article-title":"Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines","volume":"22","author":"Ibrahim","year":"2021","journal-title":"Trials"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081554","article-title":"FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare","volume":"388","author":"Lekadir","year":"2025","journal-title":"BMJ"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03408-6","article-title":"Nationwide real-world implementation of AI for cancer detection in population-based mammography screening","volume":"31","author":"Eisemann","year":"2025","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00298-X","article-title":"Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study","volume":"24","author":"L\u00e5ng","year":"2023","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1915221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:23:35Z","timestamp":1788413015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1915221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":40,"alternative-id":["10.3389\/fonc.2026.1915221"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1915221","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1915221"}}